Pembrolizumab (MK-3475) as Maintainance in Treated Patients With Unresectable Stage III NSCLC
Clinical trial NCT03379441 · UNKNOWN
Trial details
- NCT number
- NCT03379441
- Sponsor
- University of Turin, Italy
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2023-01-01
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.